KB

Karunakara Babu Suganthi Sirun Babu

Active Director Director DIN 08957808
DIN 08957808 First appointment Nov 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Karunakara Babu Suganthi Sirun Babu

Data last updated:

Karunakara Babu Suganthi Sirun Babu is a Director at New Jana Pharma Private Limited (since 2020). The company operates in Healthcare.

DIN 08957808
Primary Designation Director
Industry Healthcare
First Appointment 11 Nov 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
New Jana Pharma Private Limited U51909KL2020PTC065672
Director11 Nov 20202020Active

Board colleagues of Karunakara Babu Suganthi Sirun Babu

Directorship timeline

Open interactive timeline →
New Jana Pharma Private Limited
Premium access

Shareholding and investment profile for Karunakara Babu Suganthi Sirun Babu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karunakara Babu Suganthi Sirun Babu

Karunakara Babu Suganthi Sirun Babu currently holds 1 directorship: New Jana Pharma Private Limited (Director, since 11 Nov 2020).

Karunakara Babu Suganthi Sirun Babu was first appointed on 11 Nov 2020 as Director at New Jana Pharma Private Limited.

The current boards of Karunakara Babu Suganthi Sirun Babu's companies include Shammi Kapoor Muhammadsali (New Jana Pharma Private Limited), Syamdas Sivadasan (New Jana Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available